Authors
Latest:
Bryan Davis, PsyD, MS: Future Discussion on Masculinity Norms in MSThe clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research at Cleveland Clinic details the interventions for men with MS and how the study can change the discussion on masculinity norms.
Latest:
Awareness Empowers Care for Patients With Parkinson DiseaseParkinson disease is neither imminently fatal nor transient but is incurable, and as it affects individuals differently based on their unique identities, culture, access to health care, and social support, it is vital to empower patients.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
Question and Answer about Neurofilament Light Chain and Other MS BiomarkersMark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, answer questions about biomarkers in MS care.
Latest:
Unmet Needs in the Treatment of Spinal Muscular AtrophyA panel of experts considers current unmet needs in SMA by emphasizing the need for further study of combination therapy, more comprehensive newborn screening, and more effective early diagnosis and treatment.
Latest:
Alexander Kolevzon, MD: The STARS Study in Angelman SyndromeThe director of Child and Adolescent Psychiatry at Mount Sinai Health System spoke about the results of the phase 2 study of OV101 (gaboxadol), and the next steps for the phase 3 trial.
Latest:
Unraveling the Complexity of Fatigue in Multiple Sclerosis: John DeLuca, PhDThe senior vice president for Research and Training at Kessler Foundation talked about the issue of fatigue in patients with multiple sclerosis and the significant, multifaceted challenges patients face. [WATCH TIME: 5 minutes]
Latest:
Hillary Thomas, PhD: Screening Patients With Epilepsy for DepressionThe pediatric psychologist at Children’s Medical Center discussed what her team does to assess patients in the clinic when something comes up as a result of a patient’s screening.
Latest:
Dan Barber, MBA: Advantages of Diazepam Buccal Soluble Film FormulationThe SVP and chief strategy and development officer at Aquestive Therapeutics discussed the hope to provide both patients and providers with a more favorable, and still efficacious, option for seizure clusters.
Latest:
How Big Data Can Drive Advancements in MS ResearchBig data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.
Latest:
Bernd Feige, PhD: Insomnia and the REM Sleep StateThe study presents direct evidence that subjective experiences of insomnia may be coupled to the REM sleep state.
Latest:
Everyone Is Working Hard: Why Shift Work Shouldn't Be CelebratedDanielle B. Cross, MD, MS, a neurology resident in training, shares her thoughts on why glorifying exhaustion is unhealthy.
Latest:
Mechanistic Effectiveness of Combined Approach With Nusinersen and Zolgensma: Crystal Proud, MDThe director of neurology and neuromuscular medicine at the Children’s Hospital of the King’s Daughters in Norfolk, Virginia, provided background on findings from the phase 4 RESPOND study, and the potential of combining therapeutic approaches in SMA. [WATCH TIME: 4 minutes]
Latest:
Addressing Specific Social Determinants of Health in Epilepsy: Joseph Sirven, MDThe professor of neurology at Mayo Clinic detailed ways to address social determinants of health and the gaps in care for patients with epilepsy.
Latest:
Margaret Moline, PhD: Next-Morning Residual Effects of Lemborexant in InsomniaThe International Project Team Lead spoke about the results of study endpoints that assessed the potential for next-morning residual effects of lemborexant, which is in development for insomnia.
Latest:
Navigating Insurance and Access Issues in MigraineCurrent hurdles faced by neurologists when prescribing therapy to treat migraine and advice to help other healthcare professionals as well as patients navigate insurance and access issues.
Latest:
Uri Kramer, MD: Treating Epilepsy With CannabisThe professor of pediatrics at Tel Aviv University explained what has been fleshed out by the research and shared his opinion on cannabidiol’s use.
Latest:
Christos Papadelis, PhD: The HOPE Project in EpilepsyThe head of the Children’s Brain Dynamics Laboratory at Boston Children’s Hospital discussed the HOPE project and its goals moving forward.
Latest:
Sarah Wilson, PhD: Long-Term Social Outcomes of Epilepsy SurgeryThe clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne discussed the results of a study she and colleagues conducted in which they mapped the long-term social outcomes of patient post-epilepsy surgery.
Latest:
The Importance of Lifestyle Changes in Multiple Sclerosis CareAhmed Obeidat, MD, PhD, Riley Bove, MD, Stephen Krieger, MD, and Erin Longbrake, MD, PhD, review the benefits of exercise and physical activity in patients with MS. They also discuss strategies for talking to patients about the positive effects of lifestyle changes.
Latest:
Newborn Screening for Earlier Diagnosis of Duchenne Muscular Dystrophy: Emma Ciafaloni, MDThe professor of Neurology and Pediatrics at University of Rochester Medical Center speaks spoke on the evolving treatments for Duchenne muscular dystrophy and the possibility of earlier diagnosis through newborn screening. [WATCH TIME: 4 minutes]
Latest:
Highly Effective Gene Therapies for SMA: Where Do We Go From Here?Neuromuscular medicine has entered an era of genetic therapy, opening the doors to questions about possible combination approaches and earlier initiation of treatment.
Latest:
Dravet Syndrome: Transition of Care Into AdulthoodJoseph Sullivan, MD, and Elaine C. Wirrell, discuss the transition of care into adulthood of patients with Dravet syndrome.
Latest:
Use of Antiemetics in Parkinson CareIn this conversation, Kremens discussed the common use of antiemetics in Parkinson disease, the real-world data surrounding these agents, and whether there are certain clinical advantages to apomorphine hydrochloride injection.
Latest:
Future Directions in Research and TreatmentLooking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.
Latest:
Fred Rincon, MD, MSc: Increasing Use of Mobile Stroke UnitsThe chief of cerebrovascular disease at Jefferson University Hospitals detailed the importance and growth of mobile stroke units.
Latest:
Peter LeWitt, MD: Enhancing the Understanding of Parkinson for Therapeutic DevelopmentThe director of Parkinson’s Disease and Movement Disorders Program at Henry Ford Hospital discussed this pipeline of therapies and the enhancement of the clinical understanding of the disease.
